Results 111 to 120 of about 4,900 (222)

Preparation and Evaluation of W/O/W Multiple Emulsion Containing Naltrexone Hydrochloride: A Pilot Study [PDF]

open access: green, 2009
Bérgson F. Oliveira   +3 more
openalex  

Does Misery Love Company? Evidence from pharmaceutical markets before and after the Orphan Drug Act [PDF]

open access: yes
With substantial fixed costs of drug development, more common conditions can support more products. If additional pharmaceutical products are beneficial, they will attract greater consumption and promote better health, e.g. greater longevity.
Frank R. Lichtenberg, Joel Waldfogel
core  

Technical report on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]oxolane-2-carboxamide (tetrahydrofuranylfentanyl; THF-F). Annex 1 to the Risk Assessment Report on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]oxolane-2- carboxamide (tetrahydrofuranylfentanyl). [PDF]

open access: yes
In accordance with Article 6 of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive ...
Almeida, A   +9 more
core  

Quantitative assessment of light discomfort thresholds in a patient with photoallodynia treated with topical naltrexone 0.01. [PDF]

open access: yesAm J Ophthalmol Case Rep
Lixi F   +7 more
europepmc   +1 more source

Investigating the Landscape of C6-Azaindole Side Chain on the Epoxymorphinan Skeleton via the Nitrogen Walk Concept: A Strategy to Enhance Drug-Like Properties. [PDF]

open access: yesJ Med Chem
Neel L   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy